TREM2 and neurodegenerative disease [2]

New England Journal of Medicine

Volumn 369, Issue 16, 2013, Pages 1565-1567

  Rajagopalan, Priya ^a   Hibar, Derrek P ^a   Thompson, Paul M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; BRAIN MAPPING; BRAIN SIZE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; INTRACELLULAR SIGNALING; LETTER; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; TREM2 GENE; AGED; ATROPHY; BRAIN; GENETICS; MUTATION; ORGAN SIZE; PATHOLOGY; RISK;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MUTATION; NEURODEGENERATIVE DISEASES; ORGAN SIZE; RECEPTORS, IMMUNOLOGIC; RISK;

EID: 84885692693     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1306509     Document Type: Letter

References (3)

1. Benitez BA, Cooper B, Pastor P, et al. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol Aging 2013;34(6):1711.e15-1711.e17.
2. Hua X, Hibar DP, Ching CRK, et al. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage 2013;66:648-61.
3. Sunderland T, Linker G, Mirza N, et al. Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003;289:2094-103.